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http:WHAT THIS PAPER ADDS?
Plaque composition and speciﬁcally vulnerability are increasingly important in identifying patients at risk for
cerebrovascular events. Visualisation of these plaque characteristics by magnetic resonance imaging (MRI) has
been suggested as a valuable tool in clinical work-up. In this review we summarise the available literature for the
current state of MRI of the carotid plaque veriﬁed by histology and reporting on diagnostic accuracy. This review
attempts to provide information on possible implementation of plaque imaging by MRI in diagnostic work-up.
Existing literature on MRI versus plaque characteristics shows high diversity in technical parameters and
histological work-up. Future studies must be more structured using predeﬁned protocols.Objective: The article aims to provide an overview of the literature that assessed the agreement between
magnetic resonance imaging (MRI) and histology for speciﬁc carotid plaque characteristics associated with
vulnerability in terms of sensitivity and speciﬁcity.
Methods: A systematic search strategy was conducted in MEDLINE and EMBASE databases resulting in 1084
articles. Finally, we included 17 papers. Due to variation in presentation, especially in MRI and histology methods,
a pooled analysis could not be performed.
Results: Two studies were performed on a 3.0-T MRI scanner; all other studies were performed on a 1.5-T
scanner. Most performed sequences were two-dimensional (2D) and three-dimensional (3D) T1-weighted and all
histology protocols varied slightly. Our results indicate that calciﬁcation, ﬁbrous cap, intraplaque haemorrhage
and lipid-rich necrotic cores can be identiﬁed with moderate-to-good sensitivity and speciﬁcity.
Conclusions: Based on current literature, it appears premature for routine application of MRI as an imaging
modality to assess carotid plaque characteristics associated with plaque vulnerability. Although MRI still holds
promise, clinical application for plaque characterisation would require consensus regarding MRI settings and
conﬁrmation by histology. Predeﬁned protocols for histology and MR imaging need to be established.
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HistologyLarge randomised trials for symptomatic1,2 and asymp-
tomatic3,4 patients with high-grade (70%) carotid artery
stenosis have conﬁrmed the beneﬁt of carotid endarterec-
tomy (CEA). Currently, patient selection for CEA still merely
depends on symptoms and degree of stenosis.5 Several
studies, however, have suggested the relative importance of
plaque characteristics, rather than stenosis, in relation to
the future risk for stroke on both the short and the long
term.6e8 Furthermore, local atherosclerotic plaquerresponding author. Tel.: þ31 6 21540910.
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//dx.doi.org/10.1016/j.ejvs.2012.10.022composition in patients undergoing CEA has been shown to
be an independent predictor of future cardiovascular
events.9
Non-invasive imaging might become increasingly impor-
tant for identifying plaque characteristics in vivo. Validated
histological markers for plaque vulnerability are a thin
ﬁbrous cap (FC), a lipid-rich necrotic core (LRNC), intra-
plaque haemorrhage (IPH) or thrombus and, of less
importance, calciﬁcation.10
Development of new imaging modalities, or adaptation
of existing techniques to visualise carotid atherosclerotic
plaque characteristics in more detail, is clearly needed and
in progress.11 For non-invasive imaging, it is of eminent
importance that the major characteristics associated with
vulnerability, and especially clinical outcome, can be
Table 1. Search terms.a
(((carotid*[tiab] OR extracranial[tiab]) AND (artery[tiab] OR vessel
[tiab] ORbifurcation[tiab]) AND (stenosis[tiab]OR stenoses[tiab]
OR atherosclerosis[tiab] OR atheroscleroses[tiab] OR disease
[tiab] OR diseases[tiab])) OR “carotid stenosis”[tiab] OR “carotid
stenoses”[tiab] OR “carotid atherosclerosis”[tiab] OR “Carotid
artery diseases”[MesH] OR “Carotid stenosis”[MesH]) AND
(“magnetic resonance imaging”[tiab] OR MRI[tiab] OR MR[tiab]
OR “MR-imaging”[tiab] OR “tesla”[tiab] OR 1,5T[tiab] OR “1,5
tesla”[tiab] OR 3T[tiab] OR “3 tesla”[tiab] OR 7T[tiab] OR “7
tesla”[tiab]OR “magnetic resonance angiography”[tiab] OR “MR
angiography”[tiab] OR MRA[tiab] OR ((MR[tiab] AND DTI[tiab])
OR (MRDTI[tiab]))) AND (plaque[tiab] OR histolog*[tiab] OR
patholog*[tiab])
a Search strategy for MedLine is shown; the same search strategy
was used in EMBASE; only ‘‘[tiab]’’ had to be exchanged for
‘‘:ti,ab’’.
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resonance imaging MRI (hrMRI) seems one of the most
promising techniques to reliably determine degree of
stenosis and in addition identify carotid plaque morphology
and vessel wall structure more precisely.12 This review
assessed the agreement between MRI and histology for
speciﬁc carotid plaque characteristics associated with
vulnerability in terms of sensitivity and speciﬁcity.
METHODS
Search strategy
MEDLINE and EMBASE databases were systematically
searched on all studies relating carotid artery stenosis, MRI
and endarterectomy-derived plaque histology to include all
possible eligible studies (Table 1). This search was con-
ducted in July 2012 according to the search strategy and
data collection guidelines of the Preferred Reporting Items
for Systematic Reviews and Meta-analyses (PRISMA) state-
ment.13 A manual search of the Cochrane Library yielded no
relevant articles.Study selection
After disregarding duplicates, the title and the abstract of
the remaining articles were independently screened by
two observers (A.H. and S.B.) according to predeﬁned
criteria. Inclusion criteria were: (1) presenting data about
patients with carotid artery stenosis, (2) reporting data on
the diagnostic accuracy of MRI and (3) histology as
a reference test. Review articles, letters, comments,
abstracts for conferences, case reports <10 and animal
studies were eliminated. Subsequently, the full text of the
remaining articles was read, and articles were excluded if
one of the following criteria were applicable: (1) no
comparison with reference test, (2) ex vivo imaging, (3)
not written in English, (4) outcome not speciﬁed per
plaque characteristic and (5) unavailable full-text report
after all efforts were taken to retrieve the report,
including contacting the authors. Reference lists of the
included articles were searched manually and yielded no
relevant new articles. Disagreements between the
reviewers were resolved by consensus. A ﬂowchart of the
applied search strategy and selection process is presented
in Fig. 1.Data collection and items
A critical appraisal of the remaining full text articles was
performed by two observers (A.H. and S.B.) and relevant
data were extracted. Quality of the studies was quantiﬁed
with the QUADAS (Quality Assessment of studies of Diag-
nostic Accuracy included in Systematic reviews) tool.14
The included articles were grouped by subheadings of the
speciﬁc major plaque components: calciﬁcations, FC, IPH
and LRNC. Thrombus was not mentioned separately
because IPH consists of similar components; in addition,
these terms are interchangeably used with the addition of
luminal or intraplaque thrombus.MRI sequences, histology protocol and outcome
measures for diagnostic research were collected. Studies
varied much in presentation, especially with respect to the
MRI and histology methods. Therefore, a pooled analysis
could not be performed.
Primary outcome measures were the diagnostic accuracy
parameters, including sensitivity and speciﬁcity. In addition,
if available, the k value for comparison of histology and MRI
results was reported. A k value of >0.7 indicated good
agreement.
Data presentation
All included articles were presented per individual study in
a descriptive manner and are summarised systematically in
the tables.
RESULTS
Our search resulted in 1084 articles. After removing dupli-
cates and screening references, a critical appraisal was
performed (Table 2). This led to the exclusion of seven
articles, because for these articles sufﬁcient data extraction
was not possible. Finally, 17 articles were included. Calciﬁ-
cation was reported in four studies,15e18 FC in ﬁve,15,17,19e21
IPH in 1315e19,22e29 and LRNC in six16e18,29e31 (Fig. 1 and
Table 2).
MRI sequences
MRI protocols were speciﬁed in all studies, and slightly
different sequences or settings were used (Table 3). Two
studies were performed on 3.0-T MRI scanner26,27; all other
studies were performed on a 1.5-T scanner. Mostly two-
dimensional (2D and three-dimensional (3D) T1-weighted
(T1W) sequences were performed.
Histological analysis
Histology protocols were described in all studies. In general,
all protocols varied slightly, but most were only roughly
documented (Table 4). Within the qualiﬁed protocols to
Synonyms for 
“MRI” 
Cochrane 
N=0
PUBMED 
N=798 
N= 1572
N=1084
N= 52
N=17
Removal of 
Duplicates 
N=488
Excluded after screening Title/Abstract: 
- not fulfilling inclusion criteria n=836 
- review/letter/comment/case 
report/abstract/animal studies n=196 
Excluded after criticizing full text 
- no comparison with reference test n=9 
- ex vivo imaging n=7 
- not written in English n=1 
- outcome not specified per plaque 
characteristic n=9 
- unavailable full-text report n=2 
Included after 
reference list 
search 
N=0 
Synonyms for 
“carotid artery 
stenosis”
Synonyms for 
“histology” 
EMBASE 
N=774
Excluded after 
Critical Appraisal 
N=7 
N=24
Figure 1. Search July 2012.
A.G. den Hartog et al. 9perform histologic analysis, the American Heart Association
(AHA) classiﬁcation using a numeric classiﬁcation of eight
histological deﬁned lesion types was most often chosen.
Major carotid plaque components
The main outcome measures of the included studies are
summarised in Table 5.
Calciﬁcation. Four studies (Figs. 2 and 3) described the
detection of calciﬁcation by MRI conﬁrmed with histology.15e
18 Calciﬁcations are usually detected as hypointense areas on
all contrast weightings or as hypointense areas on two of four
sequences (T1W, T2W, proton-density weighted (PDW) and
time of ﬂight (TOF)). However, no standardised protocols
were used. The AHA classiﬁcation was used by Cai et al.15 to
assess plaque status, and calciﬁed plaques were scaled in
class VII. Saam et al.18 determined the areas of calciﬁcations
with a hypointense signal on all four weightings, and
considering all areas of calciﬁcations, the sensitivity was 76%
and the speciﬁcity was 86%. A higher sensitivity and speci-
ﬁcity were achieved when only areas >2 mm2 were consid-
ered. The correlation of MRI and histology for calciﬁcation
was good (R ¼ 0.74; P < 0.001).
Cappendijk et al.16 used a random combination of two
weightings (T1W, T2W and intermediate and partial T2W) toassess calciﬁcation and identiﬁed 100% of regions of
interest. A standard examination protocol with four
different weightings (TOF, T1, PDW and T2) was used by
Puppini et al.17 to identify calciﬁcation. Histology identiﬁed
40 of 56 sections, whereas MRI detected them in 32 of 40.
Fibrous cap. Five studies (Fig. 2, Fig. 4)15,17,19e21 reported the
appearance of the intact or ruptured FC, and only one study19
stated that the MRI protocol was not suitable for detecting FC
structure. Due to the limiting resolution of MRI and the
(usually) thin FCs, several different methods have been eval-
uated. Hatsukami et al.20 used a 3Dmultiple overlapping thin-
slab angiography sequence to investigate the capability ofMRI
in identifying FC thickness in vivo. A thick FC appeared as
a dark band between the bright lumen and grey plaque
components. The absence of this dark band with a bright grey
region directly adjacent to the lumen indicated a thin or
ruptured FC. Despite limited case numbers and wide conﬁ-
dence intervals (CIs), the observed sensitivity and speciﬁcity
for the identiﬁcation of FC rupture were promising.20 In
contrast, Albuquerque et al.19 did not ﬁnd a signiﬁcant asso-
ciation between the presence of a hyperintense MRI signal
and FC thickness (P ¼ .38). Probably the semiquantitative
analysis by histology, according to Hatsukami et al.,20 limited
their results. The T1W images did not allow evaluation of FC
Table 2. Critical appraisal with QUADAS13 tool.
Study Year Correct
patient
spectrum
Clear
selection c
riteria
Correct
reference
test
Time
between
test
Veriﬁcation Similar
reference
tests
Independent
reference
test
Hatsukami 2000 þ þ þ þ þ þ þ
Yuan 2001 þ þ þ þ þ þ þ
Cai 2002 þ þ þ þ þ þ þ
Mitsumori 2003 þ þ þ þ þ þ þ
Moody 2003 þ þ þ ? þ þ þ
Cappendijk 2004 þ þ þ þ ? þ þ
Chu 2004 þ þ þ þ þ þ þ
Kampschulte 2004 þ þ þ þ þ þ þ
Trivedi 2004 þ ? þ e þ þ þ
Cappendijk 2005 þ þ þ þ þ þ þ
Saam 2005 þ þ þ þ þ þ þ
Cai 2005 þ þ þ þ þ þ þ
Honda 2006 þ e ? e ? ? þ
Puppini 2006 þ þ þ þ þ þ þ
Liu 2006 þ e þ ? ? þ þ
Alberquerque 2007 þ þ þ ? þ þ þ
Watanabe 2008 þ þ þ ? e þ þ
Cappendijk 2008 þ þ þ þ þ þ þ
Yim 2008 þ þ þ þ þ þ þ
Yoshida 2008 þ þ þ ? þ þ þ
Bitar 2008 þ þ þ þ þ þ þ
Young 2010 þ þ þ ? þ þ þ
Ota 2010 þ þ þ ? þ þ þ
Qiao 2011 þ þ þ þ þ þ þ
þ: yes, :no, ? ¼ No results or results unclear.We added 3 questions to the standard Quadas tool.13 Are the number of patients reported?, was sufﬁcient data extraction
possible? were adequate outcome measurements reported?.
Description
of index
test
Description
of reference
test
Blinded/
correct
evaluation
of index
test
Blinded/
correct
evaluation
of reference
test
Adequate
clinical
information
Uninterpretable
results
reported
Withdrawals
explained
Number of
patients
Sufﬁcient
data
extraction
possible
Adequate
outcome
measurements
reported
Inclusion
þ þ þ þ þ þ þ þ þ þ Yes
þ þ þ þ þ þ þ þ þ þ Yes
þ þ þ þ þ þ þ þ þ þ Yes
þ þ þ þ þ þ þ þ þ þ Yes
þ þ þ þ þ þ þ þ þ þ Yes
þ þ ? þ þ e e þ e e No
þ þ þ þ þ þ þ þ þ þ Yes
þ þ þ þ þ þ þ þ þ þ Yes
þ þ ? ? þ þ þ þ ? e No
þ þ þ þ þ þ þ þ þ þ Yes
þ þ þ þ þ þ þ þ þ þ Yes
þ þ þ þ þ þ þ þ e e No
þ e ? ? þ þ e ? e e No
þ þ þ ? þ þ þ þ þ þ Yes
þ þ ? ? þ e ? þ e e No
þ þ þ þ þ þ þ þ þ þ Yes
þ þ ? þ þ ? ? þ e e No
þ þ þ þ þ þ þ þ þ þ Yes
þ þ ? þ þ þ þ þ þ þ Yes
þ þ þ þ þ ? ? þ e e No
þ þ þ þ þ þ þ þ þ þ Yes
þ ? þ þ þ þ þ þ þ þ Yes
þ þ þ þ þ þ þ þ þ þ Yes
þ þ þ þ þ þ þ þ þ þ Yes
10 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 1 January/2013structure, and were therefore only based on FC thickness. Cai
et al.15 used TOF images to determine whether FC was thick
(>0.25 mm) or ruptured. The analysis used a modiﬁed AHA
classiﬁcation that differentiated ruptured from intact FC.32,33
The modiﬁed AHA class IV/V indicates a thick or thin intact FC,
whereas AHA class VI indicates FC rupture. Mitsumori et al.21
evaluated the accuracy of in vivo multisequence MRI in
identifying the unstable FC. A strong relation was found
between the presence and the intactness of the FC. For
identiﬁcation of unstable FC in vivo, good sensitivity (81%) and
speciﬁcity (90%) were found.IPH. This characteristic was mostly positively associated
with imaging proﬁles. However, between all studies there
was no consistency in protocols used. Thirteen studies
(Fig. 2, Fig. 5) investigated the presence of IPH in the carotid
plaque in patients with carotid artery stenosis documented
by 1.5-T MRI.15e19,22e29 Two studies used a 3.0-T MRI in
identifying IPH.26,27
IPH is often diffuse and located in the LRNC, making it
difﬁcult to distinguish between these two. Several studies
report the use of multicontrast MRI to solve this problem.
Yuan et al.29 used a TOF sequence combined with a T1W
A.G. den Hartog et al. 11sequence in which the IPH and LRNC were both seen as
hyperintense, whereas on the TOF images, IPH was hyper-
intense while the LRNC was isointense.29 Because only 16
patients showed isolated IPH, no accurate assessment of
MRI for IPH alone could be made.
More authors studied the combined detection method of
TOF and T1W sequences, sometimes with addition of T2W
and PDW sequences.15,17,18,23,24,27,28,31 Chu et al.23 sub-
divided IPH into fresh (<1 week), recent (1e6 weeks) or old
(>6 weeks) haemorrhage. To distinguish between the
different stages, they used all contrast weightings. In fresh
haemorrhage, the IPH was hyperintense on T1W and TOF
images and hypointense or isointense on T2W and PDW
images. Recent IPH was hyperintense on all contrast
weightings and old IPH was hypointense on all contrast
weightings. Furthermore, Saam et al.18 identiﬁed
a moderate-to-strong correlation between MRI and
histology (R ¼ 0.66, P < 0.001).
Yim et al.28 used a slightly different approach: they
investigated the value of the high SI halo sign as a new
marker of fresh or recent IPH on the TOF sequence
speciﬁcally. A high SI halo sign around the carotid artery on
maximum intensity projection (MIP) images of TOF MRA,
compared with surgical and histopathologic ﬁndings,
demonstrated slightly lower sensitivity and speciﬁcity when
compared with the multisequence approach.
Other studies conﬁrmed speciﬁc IPH detection with MRI;
however, they only used one sequence. A T1W sequence,
MR direct thrombus imaging, dedicated to detect the
methaemoglobin in IPH, was introduced by Moody et al.25
Albuquerque et al.19 using a similar sequence, showed
excellent agreement between the histologic ﬁnding of acute
or recent haemorrhage and the MRI ﬁndings (R ¼ 0.91; 95%
CI, 0.81e1.00).
Two studies compared histology with 3.0-T MRI. Calciﬁ-
cations inﬂuenced their ability to visualise IPH, and 15
sections were excluded from analysis. On different T1W
images, IPH had a variable appearance, and on the 3D
magnetisation-prepared rapid acquisition gradient-echo
(RAGE), the signal was more hyperintense. They processed
231 MRI sections and found moderate agreement between
MRI and histology when using RAGE or fast spin echo (FSE)
sequences. Qiao et al. determined the accuracy of IPH
detection by TOF and CE-Mask images. They demonstrated
that contrast-enhanced magnetic resonance angiography
(CE-MRA) mask images can identify IPH more precisely than
the TOF sequence.27
LRNC.We identiﬁed six studies (Fig. 2, Fig. 6) that reported
the imaging of LRNC versus histology as a reference stan-
dard.16e18,29e31 Mostly, T1W sequences were used to
identify LRNC; however, the sequences used by authors
differed slightly amongst each other.
In LRNC with and without IPH, the LRNC overall accuracy
improved when no IPH was present.31 The LRNC appeared
hyperintense on the T1W scans and isointense on the TOF
scans. Saam et al. used comparable sequences when consid-
ering LRNC areas >2 mm2, and the sensitivity and thespeciﬁcity increased, with a good correlation between MRI
and histology (R ¼ 0.75, P < 0.001).18 Cappendijk et al.16
showed high sensitivity and speciﬁcity for the qualitative
detection of LRNC or IPH, or both. In further analysis, differ-
entiation between LRNCwith orwithout IPHwas tried byusing
a multisequence algorithm (T1, T2, partial T2, PDW TSE and
T1W TFE sequences) as well as a single sequence (T1W TFE).30
This showed an inter-reader agreement, expressed as
intraclass correlation coefﬁcients, for semiquantitative
analysis of LRNC of 0.86 (95% CI, 0.77e0.94) and 0.91 (95%
CI, 0.85e0.95) for multisequence and single-sequence
images, respectively.
A large LRNC area was often overestimated by MRI.
Puppini et al. showed that MRI could detect LRNC without
IPH in 34 of 56 regions versus 36 of 56 sections at
histology.17 Young et al. demonstrated by performing a DWI
sequence that LRNC could be differentiated from other
plaque components in vivo.31DISCUSSION
This review provides an overview of the existing literature
reporting non-invasive carotid plaque characterisation by
in vivo MRI with histology as a reference standard and
indicates that MRI is a valuable diagnostic tool in the
preoperative workup to detect the major carotid plaque
components in patients with carotid artery stenosis.
However, although many hrMRI studies have been pub-
lished, we were unable to perform meta-analysis due to
signiﬁcant heterogeneity in applied study methods. There-
fore, proportions for the speciﬁc plaque characteristics
remain unclear. Furthermore, the relationship between
non-invasive plaque characterisation and clinical outcome
still needs to be evaluated.
In clinical practice, duplex ultrasound (DUS) imaging
combined with computed tomography angiography (CTA) or
MRI of the carotid arteries is valuable in diagnostic work-up
to demonstrate the presence, location and extent of carotid
narrowing. These modalities can help determine the degree
of stenosis and the presence of speciﬁc plaque character-
istics. However, DUS is user dependent and CTA has con-
ﬂicting results.34e36 The presence of calciﬁcation often
overshadows other plaque characteristics and therefore it is
hard to identify the differences in plaque composition by
CT. MRI may be more accurate in identifying all plaque
characteristics and has therefore the potential to be the
ﬁrst-line non-invasive modality for the evaluation of carotid
artery stenosis and plaque composition speciﬁcally in
future. Overall, no optimal single or combined imaging
work-up for carotid stenosis has been deﬁned yet.
Several studies investigated the diagnostic ability of MRI
and most indicate MRI valuable in carotid plaque
imaging.11,37e39 Our review, based on in vivo imaging and
histology, conﬁrms this hypothesis. Therefore, we believe
implementation of hrMRI is important in the diagnostic
work-up for patients with carotid artery stenosis in the near
future. Imaging techniques such as hrMRI might be of help
in selecting patients at higher risk for cerebral adverse
Table 3. Magnetic resonance sequences of all included studies.a
First author Year Type MRI T1W T2W PDW TOF Other
Hatsukami20 2000 1.5 T SIGNA,
GE health care
NA NA NA NA 3D MOTSA
Yuan29 2001 1.5 T SIGNA,
GE health care
DIR 2D FSE Cardiac gated,
Shared echo
FSE
Cardiac gated,
Shared echo FSE
NA NA
Cai15 2002 1.5 T SIGNA,
GE health care
DIR 2D FSE Cardiac gated,
Shared echo
FSE
Cardiac gated,
Shared echo FSE
NA NA
Mitsumori21 2003 1.5 T SIGNA, GE
health care
DIR 2D FSE Cardiac gated,
Shared echo
FSE (SHARE)
Cardiac gated,
Shared echo FSE
(SHARE)
NA NA
Moody25 2003 1.5 T siemens 3D GE (MRDTI) NA NA NA NA
Chu23 2004 1.5 T SIGNA,
GE health care
BB 2D FSE (fat
suppression)
Cardiac gated,
FSE
Cardiac gated,
FSE (fat
suppression)
3D NA
Kampschulte24 2004 1.5 T SIGNA,
GE health care
Yes, not
speciﬁed
Yes, not
speciﬁed
Yes, not
speciﬁed
Yes, not
speciﬁed
NA
Cappendijk16 2005 1.5 T intera,
philips 8.1.2
2D TSE
3D TFE
ECG- gated,
TSE ECG gated
partial T2
weighted TSE
NA NA
Scout 3D TFE
NA
Saam18 2005 FSE Yes, not
speciﬁed
Yes, not
speciﬁed
Yes, not
speciﬁed
NA
Puppini17 2006 1.5 T siemens TSE TSE (shared) TSE (shared) 3D NA
Albuquerque19 2007 1.5 T
Siemens
FS 3D GE No No 3D MRA NA
Cappendijk30 2008 1.5 T intera,
philips 8.1.2
3D TFE
2D TSE
2D TSE, ECG
gated
2D TSE, ECG
gated
NA NA
Yim28 2008 1.5 T SIGNA,
GE health care
FSE
FSE with FS CE
FSE after gado
FSE Yes, not
speciﬁed
3D TOF MR
angio
NA
Bitar22 2008 1.5 T SIGNA,
GE health care
3D FS GE (IPH) No No No NA
Young31 2010 1.5 T SIGNA,
GE health care
FSE FSE shared FSE shared TOF NA
Ota26 2010 3.0 T SIGNA
excite, GE health
care & achieva,
philips
2D FSE
3D TOF
3D MP-RAGE
No No No No cardiac
gaiting
Qiao27 2011 3.0 T philips
health care
3D FFE No No 3D TOF MRA NA
MRI, magnetic resonance imaging; T1W, T1-weighted; T2W, T2-weighted; PDW, proton density weighted; TOF, time of ﬂight; MOTSA,
multiple overlapping thin slab angiography; NA, not available; T, Tesla; DIR, double inversion recovery; 2D, two-dimensional; CE, contrast
enhancent; FS, fat suppressed; FSE, fast spin echo; 3D, three-dimensional; SHARE, shared echo-FSE; BB, black blood; MRDTI, magnetic
resonance direct thrombus imaging; GE, gradient echo; TFE, turbo ﬁeld echo; TSE, turbo spin echo; IPH, intraplaque hemorrhage; MP,
magnetization prepared; RAGE, rapid acquisition gradient echo; gado, gadolinium; IR, inversion recovery.
a TSE and FSE are comparable sequences but dependent of the manufacturer of the MRI scanner used.
12 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 1 January/2013events. HrMRI might potentially be used for different
purposes: First, for the identiﬁcation of patients with
vulnerable plaques at risk for embolic events and who are
therefore appropriate candidates for surgery; second, due
to good soft tissue contrast, to reliably determine the
degree of stenosis.12,26,40 Currently, patients with mild-to-
moderate carotid stenosis remain an unclassiﬁed group.1,2
According to available literature and our ﬁndings, HrMRI
might be contributive in this sequential evaluation over
time to learn whether, for example, a less severe degree of
stenosis might be prone to cause any future symptoms.41For all patients (symptomatic and asymptomatic, less or
severe stenosis), plaque composition can have a leading
role in estimating individual future stroke risk. Therefore,
most relevantly, the search for non-invasive determination
of these plaque characteristics is an important goal for the
near future and we believe HrMRI has this potential.Accuracy of MR imaging
Our results indicate that calciﬁcation, FC, IPH and LRNC can
be identiﬁed with moderate to good sensitivity and
Table 4. Histology protocols of all included studies.
First author Year Observers Blinded for MRI
results
Time between
CEA and
histology
Direct after CEA Sectioning Staining Outcome recorded
Hatsukami20 2000 2 readers Yes NA Intact excised formalin-
ﬁxed decalciﬁed parafﬁn
embedded
Sectioned every
0.5mm-1.0 mm
Stained as
previously
describeda
FC thickness
Intact thick/intact thin/
ruptured
Yuan29 2001 1 reviewer Yes Directly Fixed in formalin
decalciﬁed embedded in
parafﬁn
10-mm sections every
0.5e1.0 mm
H&E Mallory’s
trichome
AHA classiﬁcation
Cai15 2002 1 reviewer Yes NA Fixed in formalin
decalciﬁed embedded in
parafﬁn
Sections every 0.5
e1.0-mm throughout
length
H&E Mallory’s
trichome
AHA classiﬁcation
Mitsumori21 2003 1 reviewer Yes Directly Fixed in formalin
decalciﬁed in 10% formic
acid parafﬁn-embedded
en bloc
10-mm sections every
1.0 mm in CCA and
every 0.5 mm in ACI
H&E Mallory’s
trichome V&G
Unstable FC: ulcerated,
ﬁssured, disrupted or min
thickness <0.25 mm
Moody25 2003 2 observers Yes Directly 10% formalin 5-mm
blocks parafﬁn embedding
4-mm serial sections HE Complicated plaque vs
non-complicated
Chu23 2004 1 investigator Yes NA Fixed in formalin
decalciﬁed embedded in
parafﬁn
10-mm slices every 0.5
e1 mm
H&E Mallory’s
trichome
Fresh/recent/old
hemorrhage
Kampschulte24 2004 1 reviewer Yes Directly Fixed in formalin
decalciﬁed embedded in
parafﬁn
10-mm slices every 0.5
e1 mm
H&E Mallory’s
trichome
AHA classiﬁcation/
hemorrhage and cap
thickness/rupture
Cappendijk16 2005 2 vascular
biologists 1
pathologist
Yes Directly Lateral/ventral ink
formalin 3 mm sections
embedded in parafﬁn
4-mm sections H&E EvG Plaque components :
ﬁbrous tissue lipid core
calciﬁcations IPH
Saam18 2005 1 reviewer Yes NA Fixed in 10% formalin
decalciﬁed embedded en
bloc in parafﬁn
10-mm slices every
1 mm common and
0.5 mm internal
H&E mallory’s
trichome
AHA classiﬁcation
Puppini17 2006 1 pathologist Yes NA Fixed in formaldehyde
decalciﬁed embedded in
parafﬁn
3-mm sections 5-mm
thick
H&E AHA classiﬁcation
Albuquerque19 2007 1 experienced
pathologist
Yes NA Posterior/cranial ink/
decalciﬁcation inclusion in
parafﬁn
10-mm sections every
3.0 mm
H&E Mallory
trichromic
IPH: acute, recent, old
Cappendijk30 2008 2 investigators Yes Directly Formalin 3-mm transverse
embedded in parafﬁn
4-mm slices of each
section
HE EvG AHA classiﬁcation
ROIs of: ﬁbrous tissue, LC,
calciﬁcation, IPH
Yim28 2008 1 pathologist Blinded NA Fixed in formalin
embedded in parafﬁn
Every 1 mm, 10-mm
sections
HE Plaque components: IPH,
ﬁbrous tissue LC,
calciﬁcations
Bitar22 2008 1 vascular
pathologist
Yes NA 10% formaldehyde
decalciﬁed embedded in
parafﬁn
500-mm intervals from
CCA-ICA 5-mm slice
thickness
H&E IPH
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14 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 1 January/2013speciﬁcity. Calciﬁcation is easily detected on all contrast
weightings and might be easiest on a bright-blood TOF
sequence. Overall sensitivity ranged from 76% to 92% and
sensitivity from 86% to 95%. FC can be evaluated by MRI and
conﬁrmed by histology with a good sensitivity (range, 81e
100%) and a good speciﬁcity (range, 80e96%). Furthermore,
the reported k values of 0.74e0.85 were considered good.
Studies that performed a multisequence protocol,
detected IPH with good sensitivity (range, 82e96%) and
speciﬁcity (range, 74e100%). In studies where only one
similar sequence was used, IPH was identiﬁed with equal
sensitivity (range, 84e100%) and speciﬁcity (range, 84e
96%). Ota et al.26 had only fair agreement for analysis of all
available MR sections. If only the larger IPH sections were
analysed, the sensitivity and speciﬁcity of detecting IPH
improved for all used sequences. The detection of LRNC by
MRI varied from 69% to 100% and sensitivity from 95% to
100%. When IPH was not present in LRNC, the sensitivity
and the speciﬁcity often improved slightly. Reviewing
images with multicontrast weightings provided the most
comprehensive evaluation.29 In the literature, IPH is one of
the most investigated plaque components as IPH is well
known to correlate with plaque vulnerability. However, it is
difﬁcult to distinguish IPH and LRNC. The literature is con-
ﬂicting about the clinical impact of differentiation between
these two components. For example, one study showed
that the presence of both these components indicated
a higher risk for plaque vulnerability and therefore might
result in more clinical events.42 On the other hand, in
a larger cohort, Hellings et al.9 showed that patients with
plaque haemorrhage or marked intraplaque vessel forma-
tion demonstrated an increased risk of a vascular event in
follow-up, in contrast to large lipid-core presence, which
was not associated with clinical outcome. Due to these
conﬂicting results in the literature and their supposed
clinical impact, we believe it might be valuable to study and
distinguish these two components more precisely with MRI.
Imaging of thrombus and microvessels needs to be
improved to establish imaging of plaque composition more
precisely and thereby predict the more hazardous plaque.
Thrombus is still merely investigated in concordance with
the IPH component.43 Unfortunately in our literature
search, we were not able to identify hrMRI studies specif-
ically focussing on thrombus or microvessels that used
histology as a reference. Possibly ultrasmall super-
paramagnetic iron oxide contrast agent (USPIO)-enhanced
MRI might be valuable in imaging vascularity or plaque
inﬂammation in vivo.44 Currently this technique is subject of
research, but did not ﬁt the scope of our review.
To take MR plaque characterisation out of the realm of
pure research and into the realm of clinical utility, an
algorithm or grading scale would be helpful. Unfortunately,
this review shows the multitude of available studies and
thereby the lack of comparable studies on the accuracy of
MRI in detecting major plaque characteristics. Large studies
with corresponding methods to accurately identify MRI as
a valuable tool are needed. Comparable sequences and
clearly described deﬁnitions of these sequences must be
Table 5. Sensitivity and speciﬁcity of magnetic resonance imaging of all included studies.
Year Patients Symptomatology Histological or radiological focus Sensitivity Speciﬁcity Kappa (k)
Calciﬁcationa
Cai15 2002 60 NS Calciﬁcation Type VII45 80% (66e91%) 94% (89e97%) k ¼ 0.74 (0.67e0.82)
Weighted k ¼ 0.79
Saam18 2005 40 NS Calciﬁcation all areas
Calciﬁcation areas >2 mm2
76%
84%
86%
91%
k ¼ 0.75(0.66e0.84)
Puppini17 2006 19 All symptomatic Calciﬁcation 80% (64e91%) 94% (70e100%) k ¼ 0.65
FCb
Hatsukami20 2000 22 NS FC rupture 89% (52e100%) 96% (81e100%) k ¼ 0.83(0.67e1.0)
Weighted k ¼ 0.87
Cai15 2002 60 NS FC Type IV/V45
FC Type VI45
84% (72e92%)
82% (72e89%)
90% (85e94%)
91% (86e95%)
k ¼ 0.74 (0.67e0.82)
Weighted k ¼ 0.79
Mitsumori21 2003 18 NS Unstable FC 81% (63e93%) 90% (79e96%) NS
IPH
Yuan29 2001 18 NS IPH alone
IPH þ LRNC
NS
85% (78e92%)
NS
92% (86e98%)
NS
k ¼ 0.69 (0.53e0.85)
Cai15 2002 60 NS IPH Type VI45 82% (72e89%) 91% (86e95%) k ¼ 0.74 (0.67e0.82)
Weighted k ¼ 0.79
Moody25 2003 63 All symptomatic IPH Type VI45 84% (70e93%) 84% (60e97%) k ¼ 0.75 (interobsever)
k ¼ 0.90 (intraobserver)
Chu23 2004 27 13 symptomatic
14 asymptomatic
IPHReader 1
IPHReader 2
IPHOverall IPH (Reader1&Reader 2)
95% (90e98%)
85% (78e90%)
90% (86e93%)
62e89%)
70% (55e83%)
74% (63e83%)
k ¼ 0.74 (reader 1)
k ¼ 0.52 (reader 2)
Kampschulte24 2004 26 NS Any hemorrhage
JLH/T
96% (91e98%)
88% (73e96%)
82% (69e91%)
98% (94e100%)
k ¼ 0.82 (0.74e0.89)
Cappendijk16 2005 11 Symptomatic IPH and/or LRNC Qualitative
IPH and/or LRNC Semi-quantitative
93% (77e99%)
76% (56e90%)
96% (86e100%)
100% (90e100%)
Saam18 2005 40 NS IPH All areas
IPH Areas >2 mm2
82%
87%
77%
84%
k ¼ 0.71 (0.61e0.80)
Puppini17 2006 19 All symptomatic IPH alone 92% (62e100%) 100% (88e100%) k ¼ 0.95
Albuquerque19 2007 72 42 sympt
28 asymptomatic
2 excluded
IPH 96% (85e99%) 96% (79e100%) k ¼ 0.91 (0.81e1.00)
Yim28 2008 135 71 symptomatic IPHHalo alone
IPHMultisequence
IPHCombined
91% (77e97%)
93% (81e99%)
93%
83% (75e91%)
85% (76e92%)
88%
0.76 (0.51e0.89)
0.79 (0.60e0.95)
0.78 (0.55e0.90)
Bitar22 2008 11 8 symptomatic IPHReader 1
IPHReader 2
Mean measures
100% (90e98%)
94% (79e99%)
97%
80% (69e89%)
88% (78e95%)
84%
0.73 (0.59e0.86)
0.77 (0.64e0.91)
0,75
Continued
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Table 5-continued
Year Patients Symptomatology Histological or radiological focus Sensitivity Speciﬁcity Kappa (k)
Ota26 2010 20 8 symptomatic IPH RAGE
IPH TOF
IPH FSE
RAGE (IPH>2.81 mm2)
FSE (IPH>2.81 mm2)
TOF (IPH>2.81 mm2)
47% (37e58%)
35% (26e45%)
47% (37e58%)
80%
70%
56%
97% (93e99%)96% (91
e98%)92% (86e96%)
97% (93e99%)
92% (86e96%)
96% (91e98%)
0.53 (0.68 >3pixels)
0.33
0.42
0.80
0.63
0.57
Quai27 2011 15 8 symptomatic IPHTOF Reader 1
IPHTOF Reader 2
IPHCE-MASK Reader 1
CE-MASK Reader 2
Mean
79% (67e89%)
79% (67e89%)
90% (80e96%)
84% (73e92%)
79%
86% (77e93%)
88% (78e94%)
98% (91e100%)
100% (93e100%)
87%
k intra: 0.84 (0.73e0.95)
k inter: 0.77 (0.67e0.88)
k intra: 0.94 (0.87e1.0)
k inter: 0.91 (0.84e0.98)
LRNC
Yuan29 2001 18 NS LRNC alone 98% (88e100%) 100% (92e100%) k ¼ 0.98 (0.93e100)
Saam18 2005 40 NS LRNC All areas
LRNC Areas >2 mm2
92%
95%
65%
76%
k ¼ 0.73 (0.62e0.82)
Cappendijk16 2005 11 All symptomatic Qualitative IPH and/or LRNC
Semi-quantitative IPH and/or LRNC
93% (77e99%)
76% (56e90%)
96% (86e100%)
100% (93e100%)
NS
NS
Puppini17 2006 19 All symptomatic LRNC alone 92% (78e98%) 95% (74e100%) k ¼ 0.85
Cappendijk30 2008 50 All symptomatic LRNC Singlesequence
LRNC Multisequence*
77e100%
82e100%
71e87%
69e86%
NS
Young31 2010 19 All symptomatic LRNC 86% (57e98% 40% (5e85%)
RAGE, rapid acquisition gradient echo; TOF, time of ﬂight; FSE, fast spin echo; IPH, intraplaque hemorrhage; FC, ﬁbrous cap; LRNC, lipid-rich-necrotic-core; T1W, T1-weighted; PDW, proton
density weighted; T2W, T2-weighted.*All histological cutoff points.
a Not speciﬁed in Cappendijk 2005.
b Not speciﬁed in Puppini, Albuquerque.
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Figure 2. A: Forest plots showing sensitivity*. B: Forest plots showing speciﬁcity (all plaque characteristics)*. FC, ﬁbrous cap; IPH, intra-
plaque hemorrhage; LRNC, lipid rich necrotic core, JLH/T, juxtaluminal hemorrhage/thrombus; RAGE, rapid acquisition gradient echo; TOF,
time of ﬂight; FSE, fast spin echo.*Calculation of forest plots not statistically possible for all studies (e.g. Saam, Yim (combined), Bitar
(mean), Qiao (mean)).
A.G. den Hartog et al. 17investigated. Performed histology protocols need to be
validated and comparable. These steps and the interpreta-
tion of in vivoMRI always in relation to ex vivo histology will
lead to deﬁnite use of MRI in the clinical setting.Figure 3. A: Forest plot showing sensitivity of calciﬁcation*. B: Forest p
not statistically possible for all studies (e.g. Saam, Cappendijk 2005).Limitations
Our study has a few limitations. First, we chose in vivo
imaging for the scope of this review. For ex vivo imaging,
the radiofrequency coil is placed very close to the plaque,lot showing speciﬁcity of calciﬁcation*. *Calculation of forest plots
Figure 4. A: Forest plot showing sensitivity of FC*. B: Forest plot showing speciﬁcity of FC*. *Calculation of forest plots not statistically
possible for all studies (e.g. Puppini, Albuquerque).
18 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 1 January/2013creating higher signal intensities and is performed without
blood ﬂow and the possibility of swallowing; therefore, no
triggering is needed and no ﬂow artefacts are seen.
However, we believe in vivo imaging reﬂects the most
realistic clinical setting.
Second, we believe it is essential to use histology as
reference test to make conclusions on the clinical application
of MRI more valuable. Studies that perform histology can
report their ﬁndings in diagnostic outcome parameters,Figure 5. A: Forest plot showing sensitivity of IPH*. B: Forest plot show
possible for all studies (e.g. Saam, Yim (combined), Bitar (mean), Qiaomaking it possible to compare and extrapolate to the clinical
setting. By retaining these conditions, many studies on MRI
had to be excluded. These excluded studies might however
still be valuable for contributing to the development in MRI
research despite not fulﬁlling our inclusion criteria.
Furthermore, plaque composition, which may predict future
events, and degree of stenosis must both be part of decision
for a speciﬁc treatment. For example, the presence of IPH in
all categories of stenosis and plaque burden suggests thating speciﬁcity of IPH*. *Calculation of forest plots not statistically
(mean)).
Figure 6. A: Forest plot showing sensitivity of LRNC*. B: Forest plot showing speciﬁcity of LRNC*. *Calculation of forest plots not
statistically possible for all studies (Saam).
A.G. den Hartog et al. 19direct characterisation of plaque composition and surface
status is necessary to fully discriminate disease severity.45
Therefore, the identiﬁcation of vulnerable plaque charac-
teristics in combination with degree of carotid stenosis might
be the most valuable. In our opinion, for a good comparison,
it is necessary that authors use predeﬁned histologic analysis
andMR sequences in studies investigating accuracy of MRI in
patients with carotid artery stenosis. This corresponds with
an earlier review of Lovett et al.46 Our review found
incomparable or poorly reported histologic or imaging
protocols, creating a potential interpretational error. To
standardise future reporting, it is advisable to use compar-
ison with a validated histologic protocol. Moreover, the
variety of methods in all included studies and the multitude
of plaque characteristics we investigated in this review
sometimes make it difﬁcult to state all the detailed infor-
mation. Despite these limitations, we believe it is still valu-
able to provide this overview of articles summarising the
current state of MRI clinically. Besides, this review may serve
as a ‘ wake-up call’ for all investigators to use standardised
imaging and histology protocols to allow comparison and
pooling of studies investigating the diagnostic accuracy of
MRI in identifying carotid plaque characteristics.Future perspectives
This current review contributes to the knowledge of in vivo
carotid MRI and comparison with histology for identiﬁcation
of the ‘vulnerable’ plaque. Future research concerning
carotid artery imaging should beneﬁt by the use of pre-
deﬁned, validated histologic and imaging protocols to make
clinical interpretation more reliable. Furthermore, applica-
tion of 3.0-T MRI and even advanced 7.0-T MRI will possibly
further boost the non-invasive identiﬁcation of more
hazardous and complicated plaques.47CONCLUSION
In vivo carotid plaque morphology imaging using MRI
demonstrates good agreement with ex vivo histological
analysis of speciﬁc plaque components. Therefore, MRI
might be valuable in diagnostic work-up of patients with
carotid artery stenosis in addition to stenosis grade.
However, although MRI still holds a promise, clinical appli-
cation for plaque characterisation would require consensus
regarding MRI settings. For this reason and based on
current literature, it may be too early to routinely apply
MRI as a diagnostic imaging modality to assess plaque
20 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 1 January/2013characteristics that have been associated with plaque
vulnerability. Predeﬁned protocols for histology and imaging
must be established to make outcomes more comparable
and clinically useful.
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